SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Abgenix, Inc. (ABGX)
An SI Board Since December 1998
Posts SubjectMarks Bans
590 38 0
Emcee:  Henry Niman Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
315re. erbitux ann. excellent post (imo) from yahoo thread.. Re: What is the relatbob zagorin-2/12/2004
314>>It would really be interesting to hear what Abgenix think that they are Icebrg-2/4/2004
313<i>what Abgenix think that they are doing...</i> No more than this nigel bates-2/3/2004
312Abgenix Begins Phase 1 Study of ABX-PTH in Patients with Secondary HyperparathyrIcebrg-2/3/2004
311Abgenix to Receive Milestone Payment from Pfizer for Third IND from Ongoing Collnigel bates-1/30/2004
310FOCUS STOCK • From S&P (BW discussion touches on ABGX) By Frank DiLorenzo, Cbob zagorin-1/27/2004
309Now they can hide behind AMGS ASS not to report study details! [eom]Miljenko Zuanic-1/20/2004
308Abgenix Announces ABX-EGF Enters Pivotal Trial in Advanced Colorectal Cancer PatIcebrg-1/20/2004
307Point is that after two years in multiple PII their best shot is THIRD line CRC.Miljenko Zuanic-1/17/2004
306I attended the ABGX presentation at the conference. I didn't fall asleep, bJMarcus-1/16/2004
305"Abgenix Seen As Undervalued " Did anyone listen whole H&Q presenMiljenko Zuanic-1/15/2004
304Abgenix Seen As Undervalued Forbes Staff , 01.07.04, 11:47 AM ET NEW YORK - JMarcus-1/7/2004
303Abgenix Announces Departure of Chief Financial Officer FREMONT, Calif.--(BUSINEbob zagorin-12/22/2003
302It will be interesting to see comparison with MLN2704. B210 Fully human anti-PSMiljenko Zuanic-11/20/2003
301BIO-Europe 2003 Presents Largest Deals in Industry November 17-19, 2003, Congresbob zagorin-11/6/2003
30012:54PM Imclone Color (IMCL) : -- Update -- News that Imclone Systems' (IMCLbob zagorin-11/5/2003
299Abgenix and AstraZeneca Successfully Close Equity Transaction for New Oncology Abob zagorin-10/29/2003
298SLOUGH, U.K., Oct. 28, 2003 (PRIMEZONE) -- Celltech Group plc (London:CCH.L - Nenigel bates-10/28/2003
297SSB: ABGX: Reports Third Quarter Financial Results mopgcw-10/27/2003
296GS Report: ABGX (IL/N): Steady clinical, partner progress, increasing loss estimopgcw-10/27/2003
295Unexpected loss dampens Abgenix news By Susan L. Thomas East Bay Business TimeIcebrg-10/27/2003
294Note from CC; 1. They are expecting to start pivotal third line (single agent?) Miljenko Zuanic-10/23/2003
293well looks like my ABGX call was a little off on timing if nothing else. what habob zagorin-10/23/2003
292CRGN selected another four mAbs during the quarter: Message 19426996 <i>&qnigel bates-10/23/2003
29112 months running figures. <pre> Oct-Sept July-June Icebrg-10/21/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News